WhitTier Trust Company’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.8K Sell
93
-10
-10% -$4.62K ﹤0.01% 735
2026
Q1
$51.1K Hold
103
﹤0.01% 721
2025
Q4
$62.7K Sell
103
-1
-1% -$568 ﹤0.01% 670
2025
Q3
$55.4K Buy
104
+27
+35% +$11.8K ﹤0.01% 670
2025
Q2
$24.2K Buy
77
+27
+54% +$8.11K ﹤0.01% 939
2025
Q1
$15.2K Buy
50
+19
+61% +$6.39K ﹤0.01% 1036
2024
Q4
$10.3K Buy
+31
New +$10.5K ﹤0.01% 1062

Other funds holding MEDP

WhitTier Trust Company's MEDP Position: Q2 2026 in Review

WhitTier Trust Company reduced its Medpace (MEDP) stake by 9.7% in Q2 2026, selling an estimated $4.62K and leaving 93 shares worth $50.8K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

WhitTier Trust Company first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $62.7K in Q4 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • WhitTier Trust Company held 93 shares of Medpace worth $50.8K as of Q2 2026.
  • WhitTier Trust Company sold 10 Medpace shares in Q2 2026, an estimated $4.62K.
  • Medpace made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #735 holding.
  • WhitTier Trust Company first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • WhitTier Trust Company's Medpace position peaked at $62.7K in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.